Phase II trial of afamelanotide for vitiligo in Singapore.
Phase of Trial: Phase II
Latest Information Update: 03 Dec 2015
At a glance
- Drugs Afamelanotide (Primary)
- Indications Vitiligo
- Focus Registrational; Therapeutic Use
- Sponsors Clinuvel Pharmaceuticals
- 03 Dec 2015 Preliminary results published in the Clinuvel Pharmaceuticals' media release.
- 06 May 2014 Status changed from not yet recruiting to recruiting, as reported by a Clinuvel Pharmaceuticals media release.
- 12 Nov 2013 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History